Kyle Gano, Chief Executive Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 72,800 shares at $132.70 ($9.7M) on 2026-01-16, disclosed to the SEC on 2026-01-20.
Seasonal sale ($9.7M) by Chief Executive Officer — this insider has traded NBIX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $132.70 | 34,588 | $4.6M | 47.5% |
| 2 | $132.70 | 34,588 | $4.6M | 47.5% |
| 3 | $132.71 | 1,812 | $240K | 2.5% |
| 4 | $132.71 | 1,812 | $240K | 2.5% |
| Total | $132.70 avg | 72,800 | $9.7M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $471K | — | Filing → |
| NBIX | SELL | 2025-01-17 | $9.2M | — | Filing → |